-
Mashup Score: 33An Economic Modeling Analysis of an Intensive GDMT Optimization Program in Hospitalized Heart Failure Patients - 1 month(s) ago
Background: The STRONG-HF trial demonstrated substantial reductions in the composite of mortality and morbidity over 6 months among hospitalized heart failure patients who were randomized to intensiv
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 6Qualitative Analysis of Patient Decisional Needs for Medications to Treat Heart Failure - 1 month(s) ago
BACKGROUND: The development of tools to support shared decision-making should be informed by patients’ decisional needs and treatment preferences, which are largely unknown for heart failure (HF) wit
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet-
Sim Pub w/ #ACC24 in #CircHF by @Ricky_Turgeon et al: Knowing is half the battle! Decision aids addressing HFrEF patients’ decisional needs re: #HeartFailure medications could enable shared decision-making #SDM https://t.co/epVsRj6tjB #AHAJournals @AHAScience @DrNancySweitzer https://t.co/ha9ieIoRtO
-
-
Mashup Score: 21Mechanically Regulating Cardiac Preload to Maximize Left Ventricular Unloading With a Transvalvular Microaxial Flow Pump - 1 month(s) ago
Correspondence to: Navin K. Kapur, MD, 800 Washington St, Box No. 80, Boston, MA 02111. Email The Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA. The Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA. The Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA. The Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA. The Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA. The Molecular
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 31Long-Term Effects of Mavacamten on Electromechanical Dispersion and Deformation in Obstructive Hypertrophic Cardiomyopathy - 1 month(s) ago
Correspondence to: Annamaria Del Franco, MD, PhD, Cardiomyopathy Unit, Careggi University Hospital, Florence 50134, Italy. Email Doctoral School of Clinical Medicine, University of Szeged, Hungary (E.D.P.). Department of Experimental and Clinical Medicine, University of Florence, Italy (I.O.). *A. Del Franco and E.D. Palinkas contributed equally. For Sources of Funding and Disclosures, see page 283. Correspondence to: Annamaria Del Franco, MD, PhD, Cardiomyopathy Unit, Careggi University Hospital,
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 7
Division of Cardiology, Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles (G.C.F.). Department of Biostatistics and Bioinformatics (H.R.A.-K.), Duke University, Durham, NC. Office of Nursing Research and Innovation, Cleveland Clinic Health System, Clinical Nurse Specialist–Kaufman Center for Heart Failure Treatment and Recovery, Heart, Vascular & Thoracic Institute, Clinic Main Campus, OH (N.M.A.). Baylor Scott and White Research Institute, Dallas, TX (J.B.). University of
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 4Pressure Overload–Induced Cardiac Hypertrophy Stimulates Tumor Growth in Tumor-Prone ApcMin Mice - 1 month(s) ago
Correspondence to: Rudolf A. de Boer, MD, PhD, Department of Cardiology, Erasmus MC, Dr Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands. Email Heart failure (HF) and cancer are leading causes of death worldwide and often coincide. A growing number of epidemiological studies have shown that patients with HF are at increased risk of cancer. 1 Providing mechanistic proof for these observations, preclinical studies have shown that HF stimulates tumor growth in mouse HF-cancer models. 1–4 Several
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0
BACKGROUND: Clinical trials in heart failure (HF) traditionally use time-to-event analyses focusing on death and hospitalization for HF. These time-to-first event analyses may have more limited abili
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 3Targeted Gene Deletion or Antagonism of the Prostaglandin E2 EP3 Receptor Protects Against Cardiac Injury Postmyocardial Infarction - 1 month(s) ago
BACKGROUND: Prostaglandin E2 acts through 4 G-protein-coupled receptors (EP1–EP4). We previously reported that activation of the EP3 receptor reduces cardiac contractility, and its expression increas
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1
BACKGROUND: Older adults have markedly increased risks of heart failure (HF), specifically HF with preserved ejection fraction (HFpEF). Identifying novel biomarkers can help in understanding HF patho
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 1Estimation of Right Atrial Pressure by Ultrasound-Assessed Jugular Vein Distensibility in Patients With Heart Failure - 1 month(s) ago
BACKGROUND: Clinical evaluation of central venous pressure is difficult, depends on experience, and is often inaccurate in patients with chronic advanced heart failure. We assessed the ultrasound-ass
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet
Sim Pub with #AHA23: An Economic Modeling Analysis of an Intensive GDMT Optimization Program in Hospitalized Heart Failure Patients #AHAJournals @AHAScience @gcfmd @NealDixit https://t.co/LHJerlaGjJ https://t.co/g6WZMF5WOJ